The Neuro’s drug discovery initiative supports research by developing assays shared with the scientific community
In the past 40 years, the model of drug discovery used by the pharmaceutical industry, while proving successful for some applications, has produced very little for neurodegenerative diseases.
“We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”“Take Parkinson’s disease, for instance: there have been zero new disease modifying medications developed in the last 40 years, despite hundreds of millions of dollars being invested in research,” says Dr. Edward Fon, whose lab focuses on molecular and cellular research into Parkinson’s disease. “We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”
The Neuro’s drug discovery initiative aims to support research by developing assays that investigate different aspects of target cells and sharing these assays with colleagues around the world. The main vehicle for sharing assays is The Neuro’s Induced Pluripotent Stem Cell (iPSC) platform, developed recently with seed money generously donated by Sebastian van Berkom and Ghislaine Saucier.
“We can provide industry-standard assays researchers can use to test compounds,” says Thomas Durcan, another Parkinson’s researcher who manages the iPSC platform. “In collaboration with researchers at Université Laval, we reprogram blood cells from patients with neurological diseases into stem cells, and then transform the stem cells into the type of neural cells most impacted in neuropathology.”
This gives researchers the ability to compare normal and diseased states of the cells within one patient, which has long been possible for some diseases but is a novel advance for neurological research. The Centre for Drug Research and Development, a Canadian nonprofit organization that aims to speed the translation of discoveries into therapies, and the international Structural Genomics Consortium have both formed partnerships with the Tanenbaum Open Science Institute to use the iPSC platform.
“If we can identify potential compounds for targeting diseases such as Parkinson’s and share them so they can be screened and tested throughout the scientific community, we can accelerate the rate of discovery,” says Dr. Fon. “Other researchers can benefit from the resources we develop, and the chances of 100 laboratories finding something useful is much greater than that of one lab working alone. If we can come up with something leading to treatment for Parkinson’s disease, that would be an incredible payback.”
Learn more: Accelerating drug discovery with Open Science
The Latest on: Open Science
via Google News
The Latest on: Open Science
- Indian scientific diaspora discuss open science policy, opportunities for innovators, young researchers at the STIP post-draft consultationon January 22, 2021 at 9:15 pm
Indian scientific diaspora, including academicians, thought leaders, stakeholders, members of Science India Forum, and distinguished community leaders from gulf countries deliberated on ...
- Rackspace Technology becomes a leader for the European Open Science Cloud marketplace providing AWS expertise for European Researcherson January 21, 2021 at 6:43 am
Rackspace Technology (TM) (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, has been selected by GEANT's new procurement framework, Open Clouds for Research Environments ...
- Rackspace Technology becomes a leader for the European Open Science Cloud marketplace providing ...on January 21, 2021 at 1:28 am
(GLOBE NEWSWIRE) -- Rackspace Technology™ (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, has been selected by GEANT’s new procurement framework, Open Clouds for Research ...
- Who is responsible for transferable skills and how can RRI and open science helpon January 18, 2021 at 2:00 am
This article explores the ESOF 2020 session about who is responsible for transferable skills and how can RRI and open science help.
- Open Science Is Essential for Trust in Skeptical Ageon January 13, 2021 at 10:31 am
How odd that anyone would oppose transparency in science while at the same time claiming to be scientific. Of course data and studies that support public policy should be public.
- Going beyond paywalls: Open up world of science with new policyon January 11, 2021 at 4:46 pm
Supporting research dissemination, in addition to supporting research itself, can be a significant step towards facilitating science in India; it can even be a model for other countries to emulate ...
- Open Science: Preparing for 2021 & beyondon January 2, 2021 at 6:13 am
UNESCO assembly of 193 member states would be approving in its 41st meeting of General Conference in November 2021 a set of Recommendations on Open Science. The rationale for these recommendations ...
- Open Hardware For Open Science – Interview With Charles Fracchiaon December 27, 2020 at 4:00 pm
Open Science has been a long-standing ideal for many researchers and practitioners around the world. It advocates the open sharing of scientific research, data, processes, and tools and ...
- Psychology Todayon December 24, 2020 at 12:39 am
Open Science, a scientific movement, is doing rounds globally; both developed as well as developing countries are excited to use this intellectual platform to advance research in their countries.
- National Research Council of Scienceon December 18, 2020 at 3:27 pm
In line with the global trend of Open Science and the sharing of research data, NST will endeavour to accelerate the transition to open access." Gino Ussi, Executive Vice President, Elsevier ...
via Bing News